TMPRSS2 and infection: Inhibitors of TMPRSS2, such as the serine protease inhibitor camostat mesylate (Ono Pharmaceutical, Osaka, Japan), have been demonstrated to impede the activity of TMPRSS2, thereby blocking the infection of lung cells by SARS-CoV-2 [132].